(AEVS) Aevis Victoria - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0478634105
AEVS: Hospitals, Hotels, Real Estate, Healthcare
Aevis Victoria SA is a diversified Swiss holding company with a strong presence in healthcare, hospitality, lifestyle, and infrastructure. Headquartered in Fribourg, the company operates through four main segments: Hospitals, Hospitality, Real Estate, and Others. Its healthcare offerings include telemedicine, ambulance services, life sciences, and specialized medical facilities such as a radiology institute, ophthalmology center, and urology clinic. The company also owns and operates day clinics, patient hotels, and stem cell therapy services, positioning itself as a comprehensive provider in Switzerlands private healthcare market.
In addition to its medical services, Aevis Victoria SA has a significant footprint in hospitality and lifestyle, managing luxury hotels, golf courses, and related amenities. Its real estate portfolio includes both commercial and residential properties, while its Others segment covers auxiliary services like parking, cleaning, sterilization, and IT solutions. As a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A., Aevis Victoria SA benefits from a strategic focus on medical innovation and operational efficiency. With a market capitalization of 1.186 billion CHF and a price-to-book ratio of 2.37, the company offers investors exposure to a diversified portfolio with a strong presence in Switzerlands growing healthcare and hospitality sectors.
Additional Sources for AEVS Stock
AEVS Stock Overview
| Market Cap in USD | 1,377m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
AEVS Stock Ratings
| Growth Rating | 7.89 |
| Fundamental | 11.8 |
| Dividend Rating | 7.78 |
| Rel. Strength | -10.5 |
| Analysts | - |
| Fair Price Momentum | 11.74 CHF |
| Fair Price DCF | - |
AEVS Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 49.2% |
AEVS Growth Ratios
| Growth Correlation 3m | -83.6% |
| Growth Correlation 12m | -76.3% |
| Growth Correlation 5y | 53.6% |
| CAGR 5y | 3.80% |
| CAGR/Max DD 5y | 0.09 |
| Sharpe Ratio 12m | -0.14 |
| Alpha | -15.55 |
| Beta | 0.154 |
| Volatility | 31.81% |
| Current Volume | 0k |
| Average Volume 20d | 4.5k |
As of April 19, 2025, the stock is trading at CHF 13.40 with a total of 0 shares traded.
Over the past week, the price has changed by +3.88%, over one month by -2.90%, over three months by -6.29% and over the past year by -10.96%.
Neither. Based on ValueRay Fundamental Analyses, Aevis Victoria is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.81 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AEVS as of April 2025 is 11.74. This means that AEVS is currently overvalued and has a potential downside of -12.39%.
Aevis Victoria has no consensus analysts rating.
According to ValueRays Forecast Model, AEVS Aevis Victoria will be worth about 12.7 in April 2026. The stock is currently trading at 13.40. This means that the stock has a potential downside of -5.37%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 15 | 11.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 12.7 | -5.4% |